About: Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.30 (-17.56%)
SVRA NASDAQ Savara Inc
Savara Inc share price
SVRA price activity
Last Price
$4.300
Change (24hr)
-0.92 USD (17.56%)
Volume
10.22M
Volume (4w avg)
-
Open
$4.18
Day Range
$4.00 - $4.52
Previous Close
$5.21
Last Trade
20 Nov, 5:16 pm GMT+0
Delayed
20 Nov, 5:16 pm GMT+0
SVRA price performance
Delayed
20 Nov, 5:16 pm GMT+0
SVRA details
SVRA Market Signals